StockNews.com started coverage on shares of Can-Fite BioPharma (NYSEAMERICAN:CANF – Get Rating) in a research note released on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $34.00 price objective on shares of Can-Fite BioPharma in a report on Monday, March […]
StockNews.com initiated coverage on shares of Can-Fite BioPharma (NYSEAMERICAN:CANF – Get Rating) in a research report released on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $34.00 price objective on shares of Can-Fite BioPharma in a research note on Monday, […]
StockNews.com started coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Rating) in a report published on Tuesday morning. The firm issued a hold rating on the stock. Can-Fite BioPharma Price Performance Shares of CANF opened at $2.10 on Tuesday. The stock has a market cap of $7.43 million, a price-to-earnings ratio of -0.57 and […]
Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF – Get Rating) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 56,200 shares, a growth of 43.4% from the March 31st total of 39,200 shares. Based on an average daily trading volume, of 86,500 shares, the days-to-cover ratio […]
Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF – Get Rating) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 56,200 shares, an increase of 43.4% from the March 31st total of 39,200 shares. Based on an average trading volume of 86,500 shares, the days-to-cover ratio is […]